133 related articles for article (PubMed ID: 19850492)
1. Taurolidine in the prevention and therapy of lung metastases.
Hoksch B; Rufer B; Gazdhar A; Bilici M; Beshay M; Gugger M; Schmid RA
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1058-63. PubMed ID: 19850492
[TBL] [Abstract][Full Text] [Related]
2. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
[TBL] [Abstract][Full Text] [Related]
3. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
4. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
6. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.
Braumann C; Ordemann J; Wildbrett P; Jacobi CA
Clin Exp Metastasis; 2000; 18(7):547-52. PubMed ID: 11688959
[TBL] [Abstract][Full Text] [Related]
7. The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Opitz I; van der Veen HC; Braumann C; Ablassmaier B; Führer K; Jacobi CA
Surg Endosc; 2003 Jul; 17(7):1098-104. PubMed ID: 12712383
[TBL] [Abstract][Full Text] [Related]
8. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
9. Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Braumann C; Menenakos C; Atanassov V; Pfirrmann RW; Guenther N; Jacobi CA
Eur Surg Res; 2008; 40(4):341-6. PubMed ID: 18303270
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine inhibits tumor cell growth in vitro and in vivo.
McCourt M; Wang JH; Sookhai S; Redmond HP
Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Jacobi CA; Peter FJ; Wenger FA; Ordemann J; Müller JM
Dig Surg; 1999; 16(5):393-9. PubMed ID: 10567800
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract][Full Text] [Related]
15. [Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model].
Jacobi CA; Sabat R; Ordemann J; Wenger F; Volk HD; Müller JM
Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S31-6. PubMed ID: 9333705
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Jacobi CA; Ordemann J; Böhm B; Zieren HU; Sabat R; Müller JM
Am J Surg; 1997 Sep; 174(3):359-63. PubMed ID: 9324156
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
19. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
[TBL] [Abstract][Full Text] [Related]
20. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
